Search results
Results from the WOW.Com Content Network
The 2010 DePuy Hip Replacement Recall was instituted when DePuy Orthopaedics, Inc., a division of Johnson and Johnson, recalled its ASR XL Acetabular metal-on-metal hip replacement system on August 24, 2010. [1] [2]
The drugmaker, which can't seem to get its act straight lately, last week received a warning letter from the U.S. Food and Drug Administration that it is illegally marketing two products. In a ...
In many other countries, DePuy operates as a brand under the Johnson & Johnson Medical organization. DePuy is currently the subject of more than 11,000 lawsuits related to its recall of faulty hip replacement systems, which lawyers and industry analysts estimate will cost parent company Johnson & Johnson billions of dollars to resolve.
Let's compare that to Johnson & Johnson's high-profile hip device recall. 37% of subsidiary DePuy's ASR hip implants, which J&J pulled in 2010, failed within five years, according to an internal ...
In medical technologies, J&J's major franchises include interventional solutions, orthopedics, surgery, and vision. [1] Heart and Cardiac. Abiomed. Ear, nose and throat ( Acclarent) (2010–2024) Eustachian Tube Balloon Dilation System [2] Navigation Balloon Dilation System [3]
The 2010 Johnson & Johnson children's product recall involved 43 over-the-counter children's medicines announced by McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson, on April 30, 2010. Medications in the recall included liquid versions of Tylenol, Tylenol Plus, Motrin, Zyrtec, and Benadryl. The products were recalled after it was ...
After four years of recalls, Johnson & Johnson still can't get its act together. The company's list of high profile recalls is long -- Tylenol, K-Y Jelly, contact lenses, artificial hips, blood ...
Between its massive over-the-counter children's medicines recall back in 2010 to its recent headache-inducing hip implant recalls, J&J. Johnson & Johnson investors have had enough with the word ...